Author: Multibagger News

Amber, the EV warranty startup, is making waves with its expansion nationwide, introducing new vehicles and a remote diagnostic scan. With a recent $3.18 million seed round, the company is making strategic moves to grow its business. AmberCare, the aftermarket warranty product for Tesla vehicles, initially launched in 10 states and is now expanding to 47 states through a partnership with Lexington National Insurance Company. The product covers various parts of the electric drivetrain and offers service at authorized shops. AmberCare will soon be available for Rivian vehicles, followed by Kia and Hyundai EVs in the future. In addition, Amber…

Bitcoin Needs These 3 Things to Hit $60,000 | Expert Analysis As the world’s best investment manager, financial market’s journalist, and SEO mastermind, I bring you the latest insights on Bitcoin’s journey to $60,000. Currently trading below crucial resistance levels, all eyes are on the $60,000 target. But for Bitcoin to reach this milestone, three key factors must align perfectly. Short orders with high leverage play a significant role in pushing up Bitcoin’s price. The liquidation of high-leverage short orders forces traders to close their positions as BTC approaches higher price levels, propelling the price even higher. Data from the…

Breaking News: Airbus Announces New Aircraft Program, Putting Pressure on Boeing BofA Securities maintains a Neutral rating on Boeing (NYSE: NYSE:) with a price target of $200.00 amidst Airbus’s recent announcement at the U.S. Chamber of Commerce 2024 Global Aerospace Summit. Airbus plans to launch a new aircraft program by the end of the decade, aiming to reduce fuel consumption by 25% compared to the A320. This move by Airbus could pose challenges for Boeing, especially as the American aerospace giant is facing possible labor strikes. The market eagerly awaits Boeing’s response to Airbus’s strategic advancements in the competitive aerospace…

Palantir (PLTR) Receives Street-High Price Target of $50 from Bank of America – Analysts Bullish on Potential Growth Bank of America has raised its price target for Palantir (NYSE:PLTR) to a new Street-high of $50 per share, up from $30, in a note released on Tuesday. The bank has reiterated its Buy rating on the stock, citing the company’s recent inclusion in the S&P 500 as a “watershed moment” for institutional investors to reassess Palantir’s long-term potential. Analysts at Bank of America compare Palantir’s current situation to the early days of mobile phones, where early estimates failed to anticipate the…

Starbucks CEO Brian Niccol’s 100-Day Plan: Revamping Customer Experience and Accelerating Growth in the U.S. and China (Multibagger) – Starbucks’ new CEO, Brian Niccol, unveiled an ambitious 100-day plan aimed at revitalizing the coffee giant’s customer experience and enhancing its coffeehouse culture across U.S. stores. Key Focus Areas Enhancing Customer Experience in the U.S. Niccol, who succeeded Laxman Narasimhan on September 9, has taken the helm during a period of tepid demand in both the U.S. and China. He emphasized that his initial focus will be on the U.S. market by optimizing the supply chain and advancing the company’s mobile…

Citigroup Investment Banking Fees Set to Surge 20% in Q3, Markets Revenue Expected to Drop: CFO Citigroup’s Chief Financial Officer, Mark Mason, revealed at a conference in New York that the bank’s investment banking fees are projected to increase by 20% in the third quarter compared to last year. This growth is attributed to a rise in activity in debt capital markets and mergers and acquisitions. However, markets revenue is anticipated to decline by about 4% after a 10% jump the previous year was not repeated in 2024. Mason also mentioned that the bank foresees a potential soft landing for…

Investment Manager Reveals: Israeli Forces Kill Two in Tulkarm – How Will This Impact the Financial Markets? Israeli security forces have recently killed two individuals in the West Bank city of Tulkarm, leading to heightened tensions in the region. The incident comes on the heels of a major military operation in the area, raising concerns about the impact on the financial markets. The armed wings of Fatah and Islamic Jihad have been engaged in clashes with Israeli forces, adding to the volatile situation. The Israeli military has not provided details on the incident, but the Palestinian health authorities have confirmed…

Welcome to TechCrunch Fintech! The latest in fintech news and updates to keep you informed about the financial world. From big raises to M&A activity, we’ve got you covered. The Big Story: Miami-based Finally picks up $200 million in debt and equity Miami-based Finally, a SMB-focused bookkeeping, accounting, and finance startup, recently raised $50 million in a Series B funding round and secured a $150 million credit line. This news comes on the heels of a $10 million growth raise, positioning Finally as a key player in the embedded fintech software space. With a multi-product platform that includes expense management,…

The Ultimate Analysis of Bitcoin’s Recent Sell-Off: What You Need to Know Cryptocurrency expert Ali Martinez has just revealed a shocking sell-off of Bitcoin worth nearly $850 million as the leading digital currency surged by 5.25%. Short-term holders took advantage of the price increase to dump a massive 14,816 BTC. Whales have also been active, with two large transactions totaling over $400 million spotted recently. Moreover, dormant Bitcoin wallets are coming back to life, with one wallet holding 19 BTC that was inactive for almost 11 years now worth over $1 million. Another wallet containing 31 BTC, last used in…

Citi Raises Price Target for Akeso Inc (9926: HK) Shares After Positive Study Results – Buy Rating Reiterated Citi has increased its price target for Akeso Inc (9926: HK) shares to HK$70.00, up from the previous HK$64.00, while reiterating a Buy rating on the stock. The adjustment follows Akeso’s recent presentation of positive HARMONi-2 study results at the World Conference on Lung Cancer (WCLC). Akeso’s Ivonescimab showed significant improvement in median progression-free survival (mPFS) in patients with PD-L1 positive (TPS≥1%) non-small cell lung cancer (NSCLC) compared to pembrolizumab. The study revealed an mPFS of 11.14 months for Ivonescimab versus 5.82…